Projects per year
Fingerprint Dive into the research topics where Britta Will is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 18 Similar Profiles
Myelodysplastic Syndromes
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Stem Cells
Medicine & Life Sciences
Hematopoietic Stem Cells
Medicine & Life Sciences
Thrombopoietin Receptors
Medicine & Life Sciences
Stem cells
Chemical Compounds
Leukemia
Medicine & Life Sciences
Hematopoiesis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2011 2023
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
9/1/18 → 8/31/23
Project: Research project
Cell Aging
Autophagy
Stem Cells
Hematopoietic Stem Cells
Neoplastic Stem Cells
Transcriptional regulation of hematopoietic stem cell fate during aging and bone marrow failure
9/22/15 → 7/31/20
Project: Research project
Hematopoietic Stem Cells
Bone Marrow
Research
Cell Aging
Cytosine
SATB1-dependent epigenetic regulation of leukemia initiating cells
9/1/11 → 9/2/11
Project: Research project
AT Rich Sequence
Epigenomics
Carrier Proteins
Leukemia
Hematopoietic Stem Cells
Publications 2007 2019
HIV portends a poor prognosis in myelodysplastic syndromes
Kaner, J. D., Thibaud, S., Jasra, S., Wang, Y., Janakiram, M., Sharma, A., Sridharan, A., Elias, H., Polineni, R., Assal, A., Weiss, L., Braunschweig, I., Steidl, U., Pradhan, K., Shastri, A., Chaitowitz, M., Zingman, B., Will, B., Mantzaris, I. & Verma, A., Jan 1 2019, In : Leukemia and Lymphoma.Research output: Contribution to journal › Article
Myelodysplastic Syndromes
HIV
Data Mining
Survival
Hematopoiesis
Mechanisms and therapeutic prospects of thrombopoietin receptor agonists
Bussel, J., Kulasekararaj, A., Cooper, N., Verma, A., Steidl, U., Semple, J. W. & Will, B., Oct 2019, In : Seminars in Hematology. 56, 4, p. 262-278 17 p.Research output: Contribution to journal › Review article
Thrombopoietin Receptors
Aplastic Anemia
Immunosuppressive Agents
Therapeutics
Idiopathic Thrombocytopenic Purpura
Phase II study of the ALK5 inhibitor galunisertib in very low-, low-, and intermediate-risk myelodysplastic syndromes
Santini, V., Valcarcel, D., Platzbecker, U., Komrokji, R. S., Cleverly, A. L., Lahn, M. M., Janssen, J., Zhao, Y., Chiang, A., Giagounidis, A., Guba, S. C., Gueorguieva, I., Girvan, A. C., Da Silva Ferreira, M., Bhagat, T. D., Pradhan, K., Steidl, U., Sridharan, A., Will, B. & Verma, A., Dec 1 2019, In : Clinical Cancer Research. 25, 23, p. 6976-6985 10 p.Research output: Contribution to journal › Article
LY-2157299
Myelodysplastic Syndromes
Fatigue
Cell Differentiation
Stem Cells
1
Citation
(Scopus)
Proteome-wide analysis of chaperone-mediated autophagy targeting motifs
Kirchner, P., Bourdenx, M., Madrigal-Matute, J., Tiano, S., Diaz, A., Bartholdy, B. A., Will, B. & Cuervo, A. M., May 1 2019, In : PLoS biology. 17, 5, p. e3000301Research output: Contribution to journal › Article
Open Access
autophagy
Autophagy
Proteome
proteome
Amino Acid Motifs
6
Citations
(Scopus)
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Shastri, A., Choudhary, G., Teixeira, M., Gordon-Mitchell, S., Ramachandra, N., Bernard, L., Bhattacharyya, S., Lopez, R., Pradhan, K., Giricz, O., Ravipati, G., Wong, L. F., Cole, S., Bhagat, T. D., Feld, J., Dhar, Y., Bartenstein, M., Thiruthuvanathan, V. J., Wickrema, A., Hilda Ye, B. & 13 others, , Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5489-5504 16 p.Research output: Contribution to journal › Article
Open Access
Myelodysplastic Syndromes
Stem Cells
Acute Myeloid Leukemia
Myeloid Progenitor Cells
Antisense Oligonucleotides